Institutional Ownership Tango Therapeutics, Inc. (TNGX)
This table provides information about the institutional ownership of Tango Therapeutics, Inc. (TNGX). We have compiled data on the 123 institutions that hold shares in the stock, with a total of 91.7 Million shares, which have been reported (via 13F filing form) to have a value of $296 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Trv Gp Iv, LLC
Boston, MA |
Nov 06, 2024 Q3 2024 |
16,859,075
shares
|
$54.5 Million
80.09% of portfolio
|
Q3 2024
Reduced 12.2%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
13,330,736
shares
|
$43.1 Million
4.45% of portfolio
|
Q4 2023
Added 52.85%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
8,198,642
shares
|
$26.5 Million
3.35% of portfolio
|
Q4 2023
Added 15.09%
|
|
|
Nextech Invest Ag
|
Nov 14, 2024 Q3 2024 |
5,533,980
shares
|
$17.9 Million
6.95% of portfolio
|
Q3 2023
New holding
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
5,023,146
shares
|
$16.2 Million
0.02% of portfolio
|
Q3 2024
Added 5.62%
|
|
|
Southpoint Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
5,000,000
shares
|
$16.2 Million
1.08% of portfolio
|
Q3 2024
Reduced 5.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,987,852
shares
|
$12.9 Million
0.0% of portfolio
|
Q2 2024
Added 3.28%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,645,303
shares
|
$11.8 Million
0.0% of portfolio
|
Q3 2024
Added 10.65%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,712,008
shares
|
$8.76 Million
3.75% of portfolio
|
Q3 2024
Reduced 6.25%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
2,694,125
shares
|
$8.7 Million
0.0% of portfolio
|
Q3 2024
Added 118.72%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
2,687,196
shares
|
$8.68 Million
0.04% of portfolio
|
Q3 2024
Added 870.08%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
2,603,897
shares
|
$8.41 Million
1.0% of portfolio
|
Q3 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,318,208
shares
|
$7.49 Million
0.0% of portfolio
|
Q3 2024
Added 26.8%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,294,206
shares
|
$7.41 Million
0.03% of portfolio
|
Q1 2024
Reduced 32.52%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
1,540,000
shares
|
$4.97 Million
0.22% of portfolio
|
Q4 2023
Added 94.02%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,368,262
shares
|
$4.42 Million
0.0% of portfolio
|
Q3 2024
Added 11.64%
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,188,349
shares
|
$3.84 Million
0.71% of portfolio
|
Q4 2023
Reduced 9.1%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
750,000
shares
|
$2.42 Million
0.06% of portfolio
|
Q3 2021
New holding
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2024 Q3 2024 |
708,385
shares
|
$2.29 Million
0.08% of portfolio
|
Q4 2023
New holding
|
|
|
Bessemer Group Inc
Woodbridge, NJ |
Nov 12, 2024 Q3 2024 |
708,384
shares
|
$2.29 Million
0.01% of portfolio
|
Q2 2022
New holding
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
630,000
shares
|
$2.03 Million
2.81% of portfolio
|
Q1 2023
New holding
|
|
|
Superstring Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
599,048
shares
|
$1.93 Million
4.04% of portfolio
|
Q3 2024
Added 418.34%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
543,497
shares
|
$1.76 Million
0.0% of portfolio
|
Q3 2024
Reduced 11.61%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
487,237
shares
|
$1.57 Million
0.0% of portfolio
|
Q3 2024
Added 18.64%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
479,250
shares
|
$1.55 Million
0.0% of portfolio
|
Q3 2024
Added 22.39%
|